Blood pressure and its variability: classic and novel measurement techniques
Current hypertension guidelines recommend using the average values of several blood
pressure (BP) readings obtained both in and out of the office for the diagnosis and …
pressure (BP) readings obtained both in and out of the office for the diagnosis and …
Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of …
Since the publication of the 2018 European Society of Cardiology/European Society of
Hypertension (ESC/ESH) Guidelines for the Management of Arterial Hypertension, several …
Hypertension (ESC/ESH) Guidelines for the Management of Arterial Hypertension, several …
Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial
DL Bhatt, M Vaduganathan, DE Kandzari, MB Leon… - The Lancet, 2022 - thelancet.com
Summary Background The SYMPLICITY HTN-3 (Renal Denervation in Patients With
Uncontrolled Hypertension) trial showed the safety but not efficacy of the Symplicity system …
Uncontrolled Hypertension) trial showed the safety but not efficacy of the Symplicity system …
Compounding benefits of cholesterol-lowering therapy for the reduction of major cardiovascular events: systematic review and meta-analysis
N Wang, M Woodward, MD Huffman… - … Quality and Outcomes, 2022 - Am Heart Assoc
Background: Mendelian randomization studies use genetic variants as natural experiments
to provide evidence about causal relations between modifiable risk factors and disease …
to provide evidence about causal relations between modifiable risk factors and disease …
Cardiovascular risk reduction after renal denervation according to time in therapeutic systolic blood pressure range
F Mahfoud, G Mancia, RE Schmieder, L Ruilope… - Journal of the American …, 2022 - jacc.org
Background Renal denervation (RDN) has been shown to lower blood pressure (BP), but its
effects on cardiovascular events have only been preliminarily evaluated. Time in therapeutic …
effects on cardiovascular events have only been preliminarily evaluated. Time in therapeutic …
Clinical trial design principles and outcomes definitions for device-based therapies for hypertension: a consensus document from the hypertension academic research …
The clinical implications of hypertension in addition to a high prevalence of both
uncontrolled blood pressure and medication nonadherence promote interest in developing …
uncontrolled blood pressure and medication nonadherence promote interest in developing …
[HTML][HTML] Durability of blood pressure reduction after ultrasound renal denervation: three-year follow-up of the treatment arm of the randomised RADIANCE-HTN SOLO …
F Rader, AJ Kirtane, Y Wang, J Daemen, P Lurz… - …, 2022 - ncbi.nlm.nih.gov
Background While the blood pressure (BP)-lowering effect of renal denervation (RDN) has
been established, long-term durability is a key prerequisite for a broader clinical …
been established, long-term durability is a key prerequisite for a broader clinical …
Cumulative systolic blood pressure load and cardiovascular risk in patients with diabetes
Background Standard measures of blood pressure (BP) do not account for both the
magnitude and duration of exposure to elevated BP over time. Objectives The purpose of …
magnitude and duration of exposure to elevated BP over time. Objectives The purpose of …
Renal denervation in hypertension patients: proceedings from an expert consensus roundtable cosponsored by SCAI and NKF
DE Kandzari, RR Townsend, G Bakris… - Catheterization and …, 2021 - Wiley Online Library
Despite the availability of efficacious pharmacological treatments, hypertension remains the
leading global cause of death and disability, 1 and rates of blood pressure (BP) control are …
leading global cause of death and disability, 1 and rates of blood pressure (BP) control are …
Systolic blood pressure time in target range and major adverse kidney and cardiovascular events
Background: Whether time-in-target range (TTR) for systolic blood pressure (SBP)
associates with adverse kidney and cardiovascular events remains incompletely …
associates with adverse kidney and cardiovascular events remains incompletely …